Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Santen
Veterinary versus human use under Article 3(d): CJEU asked to revisit Santen Veterinary versus human use under Article 3(d): CJEU asked to revisit Santen Reviewed by Dr Rose Hughes on Saturday, January 17, 2026 Rating: 5
UK takes uncompromising approach to interpretation of "the product" under Art. 3(a) SPC Regulation (Newron v Comptroller [2023] EWHC 1471) UK takes uncompromising approach to interpretation of "the product" under Art. 3(a) SPC Regulation (Newron v Comptroller [2023] EWHC 1471) Reviewed by Dr Rose Hughes on Monday, September 04, 2023 Rating: 5
The SPC alphabet: Are combination product SPCs precluded by Article 3(a), (c) and/or (d)? The SPC alphabet: Are combination product SPCs precluded by Article 3(a), (c) and/or (d)? Reviewed by Dr Rose Hughes on Monday, December 13, 2021 Rating: 5
Does the Irish Court of Appeal in Merck v Clonmel part ways from the CJEU's Santen Article 3(d) decision? Does the Irish Court of Appeal in Merck v Clonmel part ways from the CJEU's Santen Article 3(d) decision? Reviewed by Dr Rose Hughes on Monday, May 17, 2021 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.